William Guyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from William guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In William Guyer Today - Breaking & Trending Today
Mutual Advisors LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) from a buy rating to a strong-buy rating in a research note published on Saturday morning. Several other equities research analysts have also commented on the stock. Truist Financial lifted their price target on shares of Corcept Therapeutics from $36.00 to $42.00 and gave the […] ....
C M Bidwell & Associates Ltd. bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,606 shares of the biotechnology company’s stock, valued at approximately $125,000. Other hedge […] ....
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […] ....
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […] ....